PHYSICAL APPROACH TO TRANSDERMAL DRUG DELIVERY: A REVIEW
Abstract
Transdermal drug delivery system (TDDS) is the topically administered medication, which when applied to the skin, delivers the drug through the skin for systemic effect at a predetermined and controlled rate. For the drugs, having the short biological half-life, transdermal drug delivery system is convenient. It overcomes the problems like the hepatic first pass effect, improves the compliance of patients, decreases the administration frequency, and reduce the gastrointestinal side effects, peak and valley levels in the blood are avoided. Due to having an advantage of being non-invasive, this delivery has to fulfill some parameters such as high potency, better permeability through skin and non-irritation for better compliance. Skin serves as a site of drug application for local effect as well as systemic effect. There are wide varieties of drugs for which topical or transdermal is a viable option, skin penetration enhancement techniques have been developed for such drugs. There are a number of physical methods to increase drug delivery via the skin, many of which require the use of devices and some of which hold the promise to significantly expand the spectrum of drugs that can be administered transdermally to include water-soluble molecules and macromolecules. Iontophoresis and electroporation represent electrically assisted, physical approaches to enhance delivery of drugs/macromolecules across the stratum corneum. This review highlights the detailed role of physical penetration and describes their mechanism of action.
Keywords: transdermal drug delivery system, stratum corneum, skin penetration enhancer, physical enhancer, iontophoresis.
Â
Keywords:
, transdermal drug delivery system, stratum corneum, skin penetration enhancer, physical enhancer, iontophoresisDOI
https://doi.org/10.22270/jddt.v7i3.1435References
Jhawat VC, et al. "Transdermal drug delivery systems: approaches and advancements in drug absorption through skin." Int J Pharm Sci Rev Res. 2013; 20(1):47-56.
Bhowmik D, Dasari V, Duraivel S, Sampath Kumar KP. Recent Trends in Penetration Enhancer Used In Transdermal Drug Delivery System. The Pharma Innovation – Journal. Feb 2013; 2: 127-134.
Sharma A, Saini S, Rana AC, Transdermal Drug Delivery System: A Review. International Journal of research in pharmaceutical and biomedical sciences. 2013; 4(1):286-292.
Mezei M. Liposomes as penetration promoters and localizers of topically applied drugs. In Drug Permeation Enhancement: Theory and Applications, Hsieh, D.S., Ed.; Marcel Dekker: New York, NY, USA, 1994; pp. 171-198.
Ghafourian, T.; Samaras, E.G.; Brooks, J.D.; Riviere, J.E. Validated models for predicting skin penetration from different vehicles. Eur. J. Pharm. Sci. 2010; 41:612-616.
Kanikkannan N, Kandimalla K, Lamba SS, Singh M. Structures activity relationship of chemical penetration enhancers in transdermal drug delivery. Current Medicinal Chemistry 1999; 6:593-608.
Mbah, C. J., Uzor PF, Omeje O. "Journal of Chemical and Pharmaceutical Research." J. Chem. 2011; 3(3):680-700
Jaiswal PK, Kesharwani S, Kesharwani R, Patel DK, Ethosome: A new technology used as topical & transdermal delivery system, Journal of Drug Delivery and Therapeutics. 2016; 6(3):7-17
Benson, Heather AE. "Transfersomes for transdermal drug delivery." Expert opinion on drug delivery. 2006; 3(6):727-737.
Benson, Heather AE. "Transdermal drug delivery: penetration enhancement techniques." Current drug delivery 2.1 (2005): 23-33.
Morrow D.I.J. et al. "Innovative strategies for enhancing topical and transdermal drug delivery." The Open Drug Delivery Journal. 2007; 1:36-59.
Bavaskar, K et al. "The impact of penetration enhancers on transdermal drug delivery system: physical and chemical approach." Int J Phar Res Review. 2015; 4(7):14-24.
Saini S, Baghel S, Chauhan SS. "Recent development in penetration enhancers and techniques in transdermal drug delivery system." Journal of Advanced Pharmacy Education & Research Jan-Mar 2014; 4.1.
Hussain, Abid, et al. "Potential Enhancers for Transdermal Drug Delivery: A Review." International Journal of Basic Medical Sciences and Pharmacy (IJBMSP). 2014; 4.1.
Prakash U.R.T., Thiagarajan P., Transdermal Drug Delivery Systems Influencing Factors, Study Methods and Therapeutic Applications, International Journal of Pharmacy, 2012; 2(2):366-374.
Ansel’s Pharmaceutical Dosages Forms and Drug Delivery Systems, 9th Edition, Walters Kluwer (India) Pvt. Ltd., 2011, 294-311.
Ramteke K.H., Dhole S.N., Patil S.V., Transdermal Drug Delivery System: A Review, Journal of Advanced Scientific Research, 2012; 3(1):22-35.
Kumar R., Philip A., Modified Transdermal Technologies: Breaking the Barrier of Drug Permeation via the Skin, Tropical Journal of Pharmaceutical Research, 2007; 6(1):633-644.
Guy RH, Kalia YN, Delgado-Charro MB, Merino V, López A and Marro D, “Iontophoresis: electro repulsion and electro osmosisâ€, J. Control. Rel., 2000; 64:129- 132.
Dhakar R C, Maurya SD, Saluja V, From formulation variables to drug entrapment efficiency of microspheres: a technical review, Journal of Drug Delivery and Therapeutics; 2012; 2(6):128-133.
Sachan R, Bajpai M. Transdermal drug delivery system: a review. Int. J. Res. & Dev. Pharm. and Life Sci. Dec- Jan, 2013; 3(1):748-765.
Polat BE, Hart D, Langer R, Blankschtein, “Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends†J. Control. Release, 2011; 152:330–348.
Mormito Y, Mutoh M, Ueda H, Fang L, Hirayama K, Atobe M, Kobayashi D, “Elucidation of the transport pathway in hairless rat skin enhanced by low frequency sonophoresis based on the solute water transport relationship and confocal microscopy,†J. Control Release., 2005; 103:587-597.
Mitragotri S, Prausnitz MR, Langer R, “Current status and future potential of transdermal drug delivery,†Nat Rev: Drug Discov., 2004; 3:115-124.
Samant LR, Bhaskar A. "Transdermal drug delivery system: Review." Journal of Pharmacy Research Vol. 2012; 5(2):899-900.
Shingade GM et al. "Review on: recent trend on transdermal drug delivery system. Journal of Drug Delivery and Therapeutics. 2012; 2(1):66-75.
Prausnitz MR, “A practical assessment of transdermal drug delivery by skin electroporation†Adv. Drug Deliv Rev., 1999; 35:61-76.
Tipre ND, Vavia RP. Formulation Optimization and Stability Study of Transdermal Therapeutic System of Nicorandil. Informa Healthcare 2002; 7(3):325-332.
Sugar IP, Neumann E. Stochastic model for electric field-induced membrane pores. Electroporation. Biophys. Chem.1984; 19(3):211-25.
Murthy SN, “Magnetophoresis: an approach to enhance transdermal drug diffusion,†Pharmazie., 1999; 54:377-9
Jose Juan Escobar-Chavez, Isabel Marlen Rodriguez-Cruz, Clara Luisa Dominguez-Delgado. Chemical and Physical Enhancers for Transdermal Drug Delivery. Pharmacology. 2012; 978-953.
Tripathy S, Patel DK, Barob L, Naira SK, A review on phytosomes, their characterization, advancement & potential for transdermal application, Journal of Drug Delivery and Therapeutics. 2013; 3(3):147-152
Gerstel MS, Place VA. Drug delivery device. US Pat 1976:964482. 89. Trautman J, Cormier MJ, Kim HL, Zuck MG. Device for enhancing a transdermal agent flux. US Pat 2000; 83:196.
Trautman J, Wong PS, Daddona PE, Kim HL, Zuck MG. Device for enhancing transdermal agent flux. US Pat 2001:322808.
Yuzhakov VV, Sherman FF, Owens GD, Gartstein V. Apparatus and method for using an intracutaneous microneedle array. US Pat 2001:256533.
Sintov A, Krymbeck I, Daniel D, Hannan T, Sohn Z, Levin G, “Radiofrequency microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugsâ€, J. Control. Rel., 2003; 89:311-320.
Published
Abstract Display: 1451 
PDF Downloads: 1108 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.